ΔΎΉΟΦ±²₯

Meeting Coverage

AHS

American Headache Society

Migraine Disability Rising in the U.S.

Proportion of people with moderate or severe migraine disability nearly doubled

AHS over a photo of the Gaylord Rockies Resort & Convention Center in Aurora, Colorado

Latest AHS Meeting Coverage

Rimegepant Safe, Well-Tolerated for Migraine When Used Every Other Day

Trial evaluates a single drug to both treat and prevent migraine

June 15, 2022
How Safe Are Migraine Drugs for People With Cardiovascular Conditions?

Analysis is a first step to question how safe known treatments are, researcher says

June 13, 2022
Less Headache Disability in Kids During COVID Pandemic

Findings persisted even after adjusting for headache frequency

June 13, 2022
Intranasal Zavegepant Shows Promise in Acute Migraine

Pain relief as early as 15 minutes post-dose

June 12, 2022
Placebo Responses in Migraine Prevention Trials Tick Upward Over Time

How this may affect future research is unclear

June 12, 2022
Stigma Common Among Migraine Patients

Increased migraine-related stigma tied to poorer outcomes, quality of life

June 11, 2022
Migraine Patients Report Higher COVID Incidence

Do people with migraine have altered susceptibility?

June 9, 2021
Many Migraine Patients Have Mild TBI History

More migraine disability, anxiety, and depression in these people, registry data show

June 7, 2021
Low Migraine Recurrence With Intranasal DHE

Analysis shows sustained results with investigational INP104 device

June 6, 2021
Nearly Half of People With Migraine Hesitate to Seek Care

Many think their migraine wouldn't be taken seriously

June 5, 2021
Migraine History Predicts Concussion Severity

More concussion symptoms also seen post-injury

June 29, 2020
Sleep Predicts Migraine Recurrence

Sleep quality may identify patients at risk of developing chronic migraine

June 26, 2020
Dementia Linked to Previous Migraine History

Midlife migraine diagnosis boosted dementia rate by 50%, Danish study shows

June 18, 2020
Most Migraine Patients Lack Treatment

Only 15% with moderate or severe disability received preventive drugs, U.S. survey found

June 17, 2020